22q11.2 deletion syndrome is a genetic condition caused by missing DNA from one copy of chromosome 22. It can affect the heart, immune system, speech, learning and other aspects of health. However, a diagnosis does not mean that every possible feature will develop. People with the same deletion, including relatives, can have very different needs. MedlinePlus Genetics explains this variability.

Two homologous regions are shown. One retains 22q11.2 and one lacks it; the deletion does not create an extra chromosome. The extent of actual deletions varies.
Two homologous regions are shown. One retains 22q11.2 and one lacks it; the deletion does not create an extra chromosome. The extent of actual deletions varies.

Open full-size illustration (new tab)

What does the name mean?

The numbers and letters identify the chromosome region where DNA is missing. A deletion removes a segment containing several genes. This differs from a change in the spelling of a single gene.

Older records may use names such as DiGeorge syndrome or velocardiofacial syndrome. These names arose when different combinations of features were described separately. Identifying the shared chromosome deletion helped connect those clinical descriptions. The genetic report provides a more precise starting point than an older label alone. MedlinePlus describes the naming history.

Why recognition can happen at different ages

A heart difference present at birth may prompt testing early. In another person, speech difficulties, learning needs or repeated infections may bring the condition to attention later. Possible features also include hearing loss, feeding difficulties, kidney differences and low blood calcium. No single outward appearance is required for the diagnosis. The NHS Genomics Education overview describes the range of presentations.

This variation has a practical consequence: an assessment focused on the original concern may leave other needs unexplored. A speech referral and a heart referral can be parts of the same person’s care, even when they initially appear unrelated.

What testing establishes—and what it cannot predict

Chromosomal microarray, a test that measures missing or extra DNA, can identify the deletion. A routine chromosome examination, often called a karyotype, does not detect the typical small deletion. Targeted tests can be useful for relatives once the family’s deletion is known, but some targeted methods miss atypical deletions. The exact laboratory method matters when interpreting an older negative result. GeneReviews explains diagnostic methods and their limits.

A confirmed deletion establishes the genetic diagnosis. It does not provide a complete forecast of development, independence or future health. The report and the person’s clinical assessments answer different questions: what DNA is missing, and what support or treatment is needed now.

Care extends beyond the first diagnosis

Established care addresses specific findings and checks for recognized complications. This may involve heart assessment, immune testing, calcium and thyroid monitoring, hearing assessment and developmental support. Immune findings can affect decisions about live vaccines, so those decisions require clinical assessment. Speech, educational and mental health support also belong within continuing care. GeneReviews outlines management and surveillance.

Support should follow the individual’s abilities and difficulties. An increased likelihood of learning or psychiatric conditions does not establish that a particular person has one. New concerns deserve assessment rather than an assumption that the chromosome result explains everything.

What the result means for relatives

Most cases arise through a new deletion rather than inheritance from a parent. Nevertheless, parental testing can be informative even when both parents seem unaffected. A person who has the deletion has a 50% chance of passing it on in each pregnancy. That probability does not predict how mildly or severely a child would be affected. The NHS overview explains family testing and inheritance.

A useful appointment worksheet

A short written plan can turn a broad diagnosis into manageable questions. Families can bring the laboratory report and record:

  • The result: Which chromosome segment is missing, and which test found it?
  • Current needs: Which findings need treatment, support or further assessment?
  • Continuing care: Which checks are planned, and who coordinates them?
  • Family questions: Would parental or other relative testing clarify inherited risk?

Research does not yet explain every difference

Researchers are investigating how individual genes within the deleted region contribute to particular features. These relationships remain incomplete; a plausible biological explanation is not a reliable personal prediction. MedlinePlus summarizes the ongoing gene research.

For a research claim, the useful question is whether it explains biology, predicts outcomes accurately or demonstrates a treatment benefit. Those require different evidence. Established care continues to rely on clinical assessment, recognized monitoring and treatment of identified problems.